338 filings
Page 5 of 17
8-K
iuk8i mrpeam0y713am
11 Jun 21
Departure of Directors or Certain Officers
4:21pm
8-K
1h1w7pt 1e2s
8 Jun 21
Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021
8:01am
8-K
kbf zvgdj
11 May 21
Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021
8:01am
8-K
uks ieqep6
4 May 21
Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update
8:04am
DEFA14A
h4cw36d0ripqsz8
22 Apr 21
Additional proxy soliciting materials
4:15pm
8-K
zxlo1 yi6
7 Apr 21
Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021
8:01am
8-K
kmpt62gczk1f99s
22 Mar 21
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients
9:39pm
8-K
9ov5y1h55lozf6whxf
9 Mar 21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021
8:02am
8-K
ljfm506d k68k99l54
25 Feb 21
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
8:03am
8-K
e48zlvahyn3enz 0yst
10 Feb 21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021
7:04am
8-K
joy00288qec 325ad
7 Jan 21
Pacira Reports Record Revenue for 2020 of $429.6 Million
7:33am
8-K
a188psao3k 8psxic4
9 Dec 20
Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020
7:31am
8-K
bzo xx5bxpixerld75b
7 Dec 20
Departure of Directors or Certain Officers
8:01am
8-K
idd8d5y3as3a7be
12 Nov 20
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020
7:50am
8-K
ofio h4el
29 Oct 20
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update
8:04am
8-K
e1uzg eug9k1rbdjpjrq
7 Oct 20
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020
8:04am